Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011
about
Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.Estimating influenza disease burden from population-based surveillance data in the United States.Influenza hospitalizations among american indian/alaska native people and in the United States general population.Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Statin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations.A paradigm shift in vaccine production for pandemic influenza.The US Influenza Hospitalization Surveillance NetworkTiming of influenza epidemics and vaccines in the American tropics, 2002-2008, 2011-2014A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.Seasonal influenza vaccination of high-risk adults.Total Economic Consequences of an Influenza Outbreak in the United States.Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventionsAnnual public health and economic benefits of seasonal influenza vaccination: a European estimateTLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccinationInfluenza-associated hospitalizations, Singapore, 2004-2008 and 2010-2012.Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season.Using text messages to improve patient-doctor communication among racial and ethnic minority adults: an innovative solution to increase influenza vaccinationsPneumonia and influenza, and respiratory and circulatory hospital admissions in Belgium: a retrospective database study.Using an adjusted Serfling regression model to improve the early warning at the arrival of peak timing of influenza in Beijing.An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static ModelIncidence of viral respiratory infections in a prospective cohort of outpatient and hospitalized children aged ≤5 years and its associated cost in Buenos Aires, Argentina.Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperatureBurden of influenza-associated deaths in the Americas, 2002-2008Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.The burden of influenza-associated critical illness hospitalizationsVaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.Estimating the Effect of Influenza Vaccination on Nursing Home Residents' Morbidity and MortalityCost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S.Estimating the burden of influenza-associated hospitalizations and deaths in Central America.A Case of Influenza A (H3N2) Complicated by Community-Acquired Pneumonia and Death in a Young Healthy Adult during the 2013-2014 Season.Vaccination in the elderly: what can be recommended?Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study.Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza.A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.Fluzone® Intradermal Quadrivalent Influenza Vaccine.Community-based Flu Outreach Clinics in South Los Angeles: Client Satisfaction and Experiences.
P2860
Q30202827-DF636FD6-DF46-4420-903C-D39A837E411AQ30203021-15AED8BE-23A1-4B90-B33A-639E071B74ADQ30204564-28DD62B9-7766-4DFD-90E5-5FB22594ED6BQ30204584-023A88C3-4F9F-42B9-A092-3C1C0CE7AEB2Q30361076-3404A15D-A1B9-4848-AFB3-5D989A3168E1Q30373099-A61B20A3-9DFB-47A2-B381-B239289FC4C3Q30375212-D9275FB3-2D94-4A67-BD87-1FAB7AED4A05Q30377766-D6A7BE4D-F718-44EF-9C4E-A87898DD6887Q30378144-C7F88BC7-B7B1-46D1-A416-93632B509EDEQ30382844-5761C781-7CFF-4D83-A406-90D9133E60D4Q30385570-CECBDB8B-DDEA-490B-8389-92529847904EQ30387979-2583BE7B-C873-4B12-B154-6A56E334B245Q30388403-72682F2B-BF25-4B42-B498-20C41B51D4DBQ30400623-D8697979-CA53-4874-80C2-50DEE6AD7651Q30402629-0F3A19F3-E144-4043-9DB6-349A04A1E6EDQ34076633-BAE85E3E-E59A-4ADC-AD35-3892DDD8A78CQ34216832-0123C32E-9C4A-4A3E-BF40-19B1EDC0D517Q34320911-D1E66243-96C3-46EC-A85A-0FF2D0C2E1D4Q34391722-941FA247-F148-44A1-A996-F1991871210BQ35032712-0ED404F5-0A1D-4404-B6B4-0EB3289D7E39Q35104497-7282CFCC-BF3F-45DC-960A-E238D59EB793Q35574428-43305FC9-C7BB-4065-B20F-43DE74A3B626Q35723417-DC1E8C93-58E2-42AB-9352-E727435AA4EDQ35819735-5BEC6095-92DF-40E9-8A87-3DFF8FF0A3F0Q35931488-4FF9D3E3-1674-422F-BAE8-23430964FE25Q35995236-9F4B3EAF-F52A-4D3F-BB58-A7E134D31093Q36148024-488F49A3-E22A-49E4-9593-CAF5A60B6668Q36204702-B8ED4554-4EF0-4AA8-BE99-D267725A7D10Q36385284-1F828019-82DA-4D18-AE1A-72DFBB59331BQ36396691-511D8E0D-DDC2-4B34-8D8F-8D0A95E40317Q36602659-6CFB7626-E887-49EC-A56A-DFB208A936E7Q36827449-F48C5AF6-AFC2-4848-A2D6-911598CEC06EQ37010806-8C36DA9A-86B4-48E1-8027-75A9A4E091C1Q37629862-92ED23C6-455A-4ACF-A964-BE2ABFE0344DQ38220158-D897DF74-A152-4D03-A28C-A1C7DDF92995Q38671667-5291AAF7-637E-4242-BB18-3410F167A468Q38774410-1B7E1138-7396-489C-99B2-BE83B04007C7Q38904220-BBB184FF-7828-467B-A44C-FF2F732ADB61Q38908471-EC79DF59-9B34-4B8E-A242-FD06604D35FBQ38970438-76F5211E-2758-44C5-8B07-B589A0AA5F2D
P2860
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Influenza Illness and Hospital ...... n the United States, 2005-2011
@ast
Influenza Illness and Hospital ...... n the United States, 2005-2011
@en
type
label
Influenza Illness and Hospital ...... n the United States, 2005-2011
@ast
Influenza Illness and Hospital ...... n the United States, 2005-2011
@en
prefLabel
Influenza Illness and Hospital ...... n the United States, 2005-2011
@ast
Influenza Illness and Hospital ...... n the United States, 2005-2011
@en
P2093
P2860
P50
P1433
P1476
Influenza Illness and Hospital ...... n the United States, 2005-2011
@en
P2093
Carrie Reed
Deliana Kostova
James A Singleton
Joseph S Bresee
Paul M Gargiullo
Peng-Jun Lu
Po-Yung Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0066312
P407
P577
2013-06-19T00:00:00Z